Sunday 20th May, 2012   |   Welcome, guest. Please, login or register  
Monday October 25, 10:01

Depression: The trail of gene therapy

Gene therapy could be a solution for major depression not responding to any chemical treatment
Gene therapy could be a solution for major depression not responding to any chemical treatment
 

Depression covers very different realities, with variable pain intensity and duration. If a large proportion responding positively to treatment, a small number of patients do not respond to antidepressants. Either because the drugs do not produce the desired effect on them or because they act only momentarily, and in some cases, even worsen symptoms. In these severe cases, various heavier treatments are sometimes proposed: electroconvulsive therapy, brain stimulation etc.

In this therapeutic context of poverty facing severe depression, scientists have studied the interest of gene therapy. Experimentally yet. Researchers at Cornell University and Presbyterian Hospital in New York are indeed published an article in the journal Science Translational Medicine which concluded that gene therapy could be a solution for major depression not responding to any chemical treatment. Researchers injected a gene that activates a protein called "p11" as part of the brain called the nucleus accumbens. The restoration of this gene eliminated the depressive symptoms in laboratory mice (symptoms assessed by standardized protocols).

The researchers had the intuition that this protein activated p11 in the nucleus accumbens of the brain is fundamental to experience pleasure and a sense of satisfaction, absent in patients with depression. Post-mortem analysis showed that patients with major depression had abnormal rates of p11 protein. This is why Dr. Michael Kaplitt of Cornell University chose to insert the p11 gene to produce the protein in the nucleus accumbens using a virus as a vector.

He himself had successfully tested this technique for genetic treatment of patients with Parkinson's in a clinical trial (phase 1).

However, researchers do not know today with certainty whether the p11 protein is actually the protein of depression. This research is very interesting to better understand the mechanisms that are involved in depression.

 
Rate:
  •  
Please, login to rate the article.
 
 

Recommended articles:

 

Myopathy: The promise of pharmacogenetics

Histopathology of gastrocnemius muscle from patient who died of pseudohypertrophic muscular dystrophy, Duchenne type. Cross section of muscle shows extensive replacement of muscle fibers by adipose cells. (WiKi)
The children with Duchenne muscular dystrophy were able to produce the deficient protein. Hope against muscular dystrophy drug.
 

Antidepressants useless for most patients

For mild or moderate disease, these drugs are not much better than placebo
Antidepressants are probably unnecessary for the vast majority of patients to whom they are prescribed, but their effectiveness is not in doubt however in very severe forms of depression. For mild or moderate disease, these drugs are not much better than placebo.
 

Gene therapy: Reducing congenital blindness

Double helical structure of DNA
Researchers have succeeded, through gene therapy to dramatically improve vision in children who suffer from Leber congenital amaurosis (LCA), a severe genetic disease that usually leads to blindness.
 

Most recent in the category Human body:

 
 
 

Last comments

 

No comments. Be the first to comment the article!

Please, login to post comments.
 
 
 
 

Home | Social Health | AIDS | Cancer | Deseases | Diet | Human body | Most read | Top rated

RSS | Feedback | Headlines for your website | Terms of Service/Privacy policy

Copyright © 2012 Heal-all.org. All rights reserved.